Ramelteon attenuates renal ischemia and reperfusion injury through reducing mitochondrial fission and fusion and inflammation.

Authors:
Chen P; Liu W; Wei Y.

Journal:
Transl Androl Urol

Publication Year: 2023

DOI:
10.21037/tau-23-543

PMCID:
PMC10772642

PMID:
38196697

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Transl Androl Urol

Detailed journal information not available.

Publication Details

Subject Category: Andrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-543/coif). The authors have no conflicts of interest to declare."

Funding Disclosure

Evidence found in paper:

"Funding: None."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025